Literature DB >> 668720

Glucocorticosteroids and growth hormone secretion under physiological conditions and in states of steroid excess.

K E Mühlendahl, B Weber, R Müller-Hess, S Korth-Schütz, H Helge.   

Abstract

Cortisol and growth hormone (GH) secretion (spontaneous variations at night and the release induced by insulin hypoglycaemia) were investigated in 69 children and adolescents. Statistical analysis of approximately 600 pairs of cortisol and GH values in this study demonstrated that physiological fluctuations of cortisol do not alter GH secretion. A review of the literature shows that GH secretion is consistently depressed in Cushing's disease of central origin and in Cushing's syndrome due to adrenal carcinoma. When acutely administered, doses higher than 100 mg of cortisol (or equivalent amounts of other steroids) per adult are necessary to block GH secretion and the hormones have to be given several hours previously. In long-term steroid treatment, suppression of GH is observed in only 1 out of 3 patients. The effect apparently does not persist beyond elimination of the last dose, i.e. generally not longer than 12 to 24 h. These data can be taken as a rationale for intermittent or alternating dosage schedules, and for the use of short acting derivatives if long-term, high-dose steroid treatment is necessary in children. It remains to be established whether growth deficiency in exogenous hypercortisolism is due to suppression of GH secretion, decreased production of somatomedins, direct antagonism of the action of somatomedins on growing cartilage, or a combination of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668720     DOI: 10.1007/BF00496996

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  39 in total

1.  Radioimmunological determination of plasma cortisol.

Authors:  P Vecsei; B Penke; R Katzy; L Baek
Journal:  Experientia       Date:  1972-09-15

2.  Effect of corticotrophin on plasma-growth-hormone.

Authors:  V Neri; A Bartorelli; B Ambrosi; P Beck Peccoz; G Faglia
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

3.  Effect of glucocorticoids on plasma growth hormone in man.

Authors:  J N Stiel; D P Island; G W Liddle
Journal:  Metabolism       Date:  1970-02       Impact factor: 8.694

4.  Failure of suppression of nocturnal growth hormone rise by acute corticosteroid administration.

Authors:  D T Krieger; J Albin; S Paget; S M Glick
Journal:  Horm Metab Res       Date:  1972-11       Impact factor: 2.936

5.  Human growth hormone secretion during major surgical stress and the influence of pre-treatment with dexamethasone.

Authors:  K F Hanssen; V H Asfeldt
Journal:  Horm Metab Res       Date:  1972-01       Impact factor: 2.936

6.  Suppression of the hypothalamo-pituitary-adrenal axis and growth hormone release with dexamethasone.

Authors:  K von Werder; S Hane; P H Forsham
Journal:  Horm Metab Res       Date:  1971-05       Impact factor: 2.936

7.  Growth hormone in hypersecretory diseases of the adrenal gland.

Authors:  L B Morrow; R C Mellinger; J J Prendergast; A R Guansing
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

8.  Plasma growth hormone concentration in corticosteroid-treated children.

Authors:  H G Morris; J R Jorgensen; S A Jenkins
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Growth hormone secretion in growth-retarded asthmatic children.

Authors:  S S Sanders; A P Norman
Journal:  Br Med J       Date:  1969-07-05

10.  Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.

Authors:  R G Thompson; A Rodriguez; A Kowarski; R M Blizzard
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

View more
  2 in total

1.  Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

Review 2.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.